Matches in SemOpenAlex for { <https://semopenalex.org/work/W2058235887> ?p ?o ?g. }
- W2058235887 endingPage "89" @default.
- W2058235887 startingPage "83" @default.
- W2058235887 abstract "Phosphodiesterases (PDEs) have been studied in a variety of tumours; data have suggested that the levels of PDE activities are elevated and, therefore, the ratios of cGMP to cAMP are affected. In addition, PDE inhibitors are potential targets for tumour cell growth inhibition and induction of apoptosis. Nonselective PDE inhibitors, such as theophylline or aminophylline, are known regulators of growth in a variety of carcinoma cell lines, suggesting a potential role for PDE inhibitors as anticancer drugs. In the current study, we reported the synthesis of novel derivatives of 6-aryl-4-imidazolyl-2-imino-1,2-dihydropyridine-3-carbonitriles (Ia,b,c) and their 2-oxo isosteres (IIa,b,c,d). All the compounds were evaluated for their PDE3A inhibitory effects, as well as their cytotoxic effects on MCF-7 and HeLa cell lines. Moreover, structure–activity relationships were studied. 4-(1-benzyl-2-ethylthio-5-imidazolyl)-6-(4-bromophenyl)-2-imino-1,2-dihydropyridine-3-carbonitrile (Ib) exhibited the strongest PDE3A inhibitory effects with an IC50 of 3.76 ± 1.03 nM. Compound Ib also showed the strongest cytotoxic effects on both the HeLa and MCF-7 cells with an IC50 of 34.3 ± 2.6 μM and 50.18 ± 1.11 μM, respectively. There was a direct correlation between PDE3 inhibition and anticancer activity for the synthesised compounds. The data reported here support our view that PDEs represent promising cellular targets for antitumor treatment." @default.
- W2058235887 created "2016-06-24" @default.
- W2058235887 creator A5022410357 @default.
- W2058235887 creator A5058021840 @default.
- W2058235887 creator A5066655870 @default.
- W2058235887 creator A5068435169 @default.
- W2058235887 creator A5072639736 @default.
- W2058235887 date "2014-12-01" @default.
- W2058235887 modified "2023-10-12" @default.
- W2058235887 title "Synthesis and biological evaluation of novel pyridine derivatives as potential anticancer agents and phosphodiesterase-3 inhibitors" @default.
- W2058235887 cites W1575601729 @default.
- W2058235887 cites W1738497100 @default.
- W2058235887 cites W1829776237 @default.
- W2058235887 cites W1973519389 @default.
- W2058235887 cites W1976148956 @default.
- W2058235887 cites W1979461875 @default.
- W2058235887 cites W1989874233 @default.
- W2058235887 cites W1990270711 @default.
- W2058235887 cites W2035690299 @default.
- W2058235887 cites W2062047139 @default.
- W2058235887 cites W2062727983 @default.
- W2058235887 cites W2065365814 @default.
- W2058235887 cites W2081192590 @default.
- W2058235887 cites W2088763860 @default.
- W2058235887 cites W2093343991 @default.
- W2058235887 cites W2095510701 @default.
- W2058235887 cites W2099314020 @default.
- W2058235887 cites W2112100215 @default.
- W2058235887 cites W2114497687 @default.
- W2058235887 cites W2123350513 @default.
- W2058235887 cites W2152150730 @default.
- W2058235887 doi "https://doi.org/10.1016/j.bioorg.2014.09.003" @default.
- W2058235887 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25277835" @default.
- W2058235887 hasPublicationYear "2014" @default.
- W2058235887 type Work @default.
- W2058235887 sameAs 2058235887 @default.
- W2058235887 citedByCount "29" @default.
- W2058235887 countsByYear W20582358872015 @default.
- W2058235887 countsByYear W20582358872016 @default.
- W2058235887 countsByYear W20582358872017 @default.
- W2058235887 countsByYear W20582358872018 @default.
- W2058235887 countsByYear W20582358872019 @default.
- W2058235887 countsByYear W20582358872020 @default.
- W2058235887 countsByYear W20582358872021 @default.
- W2058235887 countsByYear W20582358872022 @default.
- W2058235887 countsByYear W20582358872023 @default.
- W2058235887 crossrefType "journal-article" @default.
- W2058235887 hasAuthorship W2058235887A5022410357 @default.
- W2058235887 hasAuthorship W2058235887A5058021840 @default.
- W2058235887 hasAuthorship W2058235887A5066655870 @default.
- W2058235887 hasAuthorship W2058235887A5068435169 @default.
- W2058235887 hasAuthorship W2058235887A5072639736 @default.
- W2058235887 hasConcept C154317977 @default.
- W2058235887 hasConcept C178790620 @default.
- W2058235887 hasConcept C181199279 @default.
- W2058235887 hasConcept C185592680 @default.
- W2058235887 hasConcept C202751555 @default.
- W2058235887 hasConcept C2776958096 @default.
- W2058235887 hasConcept C2777366897 @default.
- W2058235887 hasConcept C2777752497 @default.
- W2058235887 hasConcept C2781212610 @default.
- W2058235887 hasConcept C519063684 @default.
- W2058235887 hasConcept C54355233 @default.
- W2058235887 hasConcept C55493867 @default.
- W2058235887 hasConcept C62826618 @default.
- W2058235887 hasConcept C71240020 @default.
- W2058235887 hasConcept C81885089 @default.
- W2058235887 hasConcept C86803240 @default.
- W2058235887 hasConceptScore W2058235887C154317977 @default.
- W2058235887 hasConceptScore W2058235887C178790620 @default.
- W2058235887 hasConceptScore W2058235887C181199279 @default.
- W2058235887 hasConceptScore W2058235887C185592680 @default.
- W2058235887 hasConceptScore W2058235887C202751555 @default.
- W2058235887 hasConceptScore W2058235887C2776958096 @default.
- W2058235887 hasConceptScore W2058235887C2777366897 @default.
- W2058235887 hasConceptScore W2058235887C2777752497 @default.
- W2058235887 hasConceptScore W2058235887C2781212610 @default.
- W2058235887 hasConceptScore W2058235887C519063684 @default.
- W2058235887 hasConceptScore W2058235887C54355233 @default.
- W2058235887 hasConceptScore W2058235887C55493867 @default.
- W2058235887 hasConceptScore W2058235887C62826618 @default.
- W2058235887 hasConceptScore W2058235887C71240020 @default.
- W2058235887 hasConceptScore W2058235887C81885089 @default.
- W2058235887 hasConceptScore W2058235887C86803240 @default.
- W2058235887 hasLocation W20582358871 @default.
- W2058235887 hasLocation W20582358872 @default.
- W2058235887 hasOpenAccess W2058235887 @default.
- W2058235887 hasPrimaryLocation W20582358871 @default.
- W2058235887 hasRelatedWork W1974226594 @default.
- W2058235887 hasRelatedWork W2058235887 @default.
- W2058235887 hasRelatedWork W2121537953 @default.
- W2058235887 hasRelatedWork W2142063375 @default.
- W2058235887 hasRelatedWork W2181893452 @default.
- W2058235887 hasRelatedWork W2321391306 @default.
- W2058235887 hasRelatedWork W2322623868 @default.
- W2058235887 hasRelatedWork W2361659734 @default.
- W2058235887 hasRelatedWork W2604476398 @default.
- W2058235887 hasRelatedWork W2739011237 @default.